A Blessing or a Curse for RA Patients? Xeljanz, approved by the FDA in 2012, is a first-in-class drug to treat rheumatoid arthritis. But is it safe?  Check out my latest Healthline article, here => http://www.healthline.com/health-news/xeljanz-blessing-or-curse-for-ra-patients-100414 Continue reading →